Prognostic value of CIP2A gene expression in adult Egyptian acute myeloid leukemia patients

被引：0

作者：

Shafik, Roxan E. ^{[1
]}

Ibrahim, Azza M. ^{[2
]}

Said, Fadwa ^{[2
]}

Hassan, Naglaa M. ^{[1
]}

Shafik, Hanan E. ^{[3
]}

Shokralla, Hala A. ^{[3
]}

机构：

[1] Cairo Univ, Natl Canc Inst NCI, Clin Pathol Dept, Cairo, Egypt

[2] Cairo Univ, Clin Pathol Dept, Cairo, Egypt

[3] Cairo Univ, Natl Canc Inst NCI, Med Oncol Dept, Cairo, Egypt

来源：

EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS | 2020年 / 21卷 / 01期

关键词：

AML; CIP2A; RT-qPCR; TANDEM DUPLICATION; CANCER;

D O I：

10.1186/s43042-020-00075-3

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Background Protein phosphatase 2A (PP2A) functions as a tumor suppressor in many cancers. Cancerous inhibitor of protein phosphatase 2A (CIP2A) inhibits PP2A proteolytic degradation of c-Myc and enhances cell growth and tumor formation in several tissues. CIP2A expression in acute myeloid leukemia (AML) and its effect on outcome of treatment were not reported in Egyptian patients. Results No significant difference was detected in CIP2A expression between AML and control groups (P = 0.48). However, in AML patients, those with low CIP2A expression had a longer median overall survival than those with high expression (P = 0.059). CIP2A expression was not related to the clinical and laboratory variables and did not affect response to treatment. Conclusion High-CIP2A expression was associated with a trend of shorter overall survival in adult Egyptian AML patients. It might serve as a useful marker to predict poor prognosis. CIP2A may represent a potential target for cancer therapy.

引用

页数：7

共 18 条

[1] CIP2A high expression is a poor prognostic factor in normal karyotype acute myeloid leukemia [J].

Barragan, Eva ;

Chillon, Maria Carmen ;

Castello-Cros, Remedios ;

Marcotegui, Nerea ;

Prieto, Maria Isabel ;

Hoyos, Montserrat ;

Pippa, Raffaella ;

Llop, Marta ;

Etxabe, Amaia ;

Cervera, Jose ;

Rodriguez, Gabriela ;

Buno, Ismael ;

Rifon, Jose ;

Sierra, Jorge ;

Gonzalez, Marcos ;

Calasanz, Maria J. ;

Sanz, Miguel A. ;

Odero, Maria D. .

HAEMATOLOGICA, 2015, 100 (05)

[2] Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia [J].

Bullinger, L ;

Döhner, K ;

Bair, E ;

Fröhling, S ;

Schlenk, RF ;

Tibshirani, R ;

Döhner, H ;

Pollack, JR .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (16) :1605-1616

[3] Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia:: results from Cancer and Leukemia Group B (CALGB 8461) [J].

Byrd, JC ;

Mrózek, K ;

Dodge, RK ;

Carroll, AJ ;

Edwards, CG ;

Arthur, DC ;

Pettenati, MJ ;

Patil, SR ;

Rao, KW ;

Watson, MS ;

Koduru, PRK ;

Moore, JO ;

Stone, RM ;

Mayer, RJ ;

Feldman, EJ ;

Davey, FR ;

Schiffer, CA ;

Larson, RA ;

Bloomfield, CD .

BLOOD, 2002, 100 (13) :4325-4336

[4] Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia [J].

Cheson, BD ;

Bennett, JM ;

Kopecky, KJ ;

Büchner, T ;

Willman, CL ;

Estey, EH ;

Schiffer, CA ;

Döhner, H ;

Tallman, MS ;

Lister, TA ;

LoCocco, F ;

Willemze, R ;

Biondi, A ;

Hiddemann, W ;

Larson, RA ;

Löwenberg, B ;

Sanz, MA ;

Head, DR ;

Ohno, R ;

Bloomfield, CD .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) :4642-4649

[5] CIP2A Is Associated with Human Breast Cancer Aggressivity [J].

Come, Christophe ;

Laine, Anni ;

Chanrion, Maia ;

Edgren, Henrik ;

Mattila, Elina ;

Liu, Xiaoling ;

Jonkers, Jos ;

Ivaska, Johanna ;

Isola, Jorma ;

Darbon, Jean-Marie ;

Kallioniemi, Olli ;

Thezenas, Simon ;

Westermarck, Jukka .

CLINICAL CANCER RESEARCH, 2009, 15 (16) :5092-5100

[6] PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect [J].

Cristobal, I. ;

Garcia-Orti, L. ;

Cirauqui, C. ;

Alonso, M. M. ;

Calasanz, M. J. ;

Odero, M. D. .

LEUKEMIA, 2011, 25 (04) :606-614

[7] The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial [J].

Grimwade, D ;

Walker, H ;

Harrison, G ;

Oliver, F ;

Chatters, S ;

Harrison, CJ ;

Wheatley, K ;

Burnett, AK ;

Goldstone, AH .

BLOOD, 2001, 98 (05) :1312-1320

[8]

Kuykendall Andrew, 2018, Am Soc Clin Oncol Educ Book, V38, P555, DOI 10.1200/EDBK_199519

[9]

Lesaffre E, 2008, BULL HOSP JT DIS, V66, P146

[10] Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method [J].

Livak, KJ ;

Schmittgen, TD .

METHODS, 2001, 25 (04) :402-408

← 1 2 →